Data availability
Data supporting the findings of this study are available from the article.
Abbreviations
- NMOSD :
-
Neuromyelitis optica spectrum disorder
- CNS :
-
Central nervous system
- MR :
-
Mendelian randomization
- 25(OH)D :
-
25-Hydroxyvitamin D
- GWAS :
-
Genome-wide association study
- AQP-4 :
-
Aquaporin-4
- Ab :
-
Antibody
- UK :
-
United Kingdom
- SNPs :
-
Single-nucleotide polymorphisms
- LD :
-
Linkage disequilibrium
- IVW :
-
Inverse variance weighted
- MR-PRESSO :
-
MR Pleiotropy Residual Sum and Outlier
- OR :
-
Odds ratio
- CI :
-
Confidence intervals
- Th :
-
T helper
References
Huda S, Whittam D, Bhojak M, Chamberlain J, Noonan C, Jacob A (2019) Neuromyelitis optica spectrum disorders. Clin Med (Lond) 19(2):169–176
Lucas RM, Ponsonby AL, Dear K, Valery PC, Pender MP, Taylor BV et al (2011) Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 76(6):540–548
Min JH, Waters P, Vincent A, Cho HJ, Joo BE, Woo SY et al (2014) Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability. PLoS ONE 9(9):e107274
Puangsricharoen B, Vanikieti K, Jindahra P, Padungkiatsagul T (2022) Serum vitamin D levels and status in Thai Optic Neuritis Subjects: a case-control study. Clin Ophthalmol 16:3381–3389
Tüzün E, Küçükhüseyin Ö, Kürtüncü M, Türkoğlu R, Yaylım İ (2015) Reduced serum vitamin D levels in neuromyelitis optica. Neurol Sci 36(9):1701–1702
Fletcher J, Bishop EL, Harrison SR, Swift A, Cooper SC, Dimeloe SK et al (2022) Autoimmune disease and interconnections with vitamin D. Endocr Connect 11(3)
Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1,25–dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179(3):1634–1647
Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A (2001) 1alpha,25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167(9):4974–4980
Koduah P, Paul F, Dörr JM (2017) Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases. Epma J 8(4):313–325
Acknowledgements
We acknowledge the investigators and participants of the original GWAS. We are grateful for all GWAS sharing summary data used in this study.
Funding
This work was supported by National Natural Science Foundation of China, 82371365, Qun Xue,Jiangsu Provincial Natural Science Foundation, BK20211075, Qun Xue, Soochow University Collaborative Innovation Centre, H230028, Qun Xue.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Since the GWAS data from published studies were used for the study, there was no need for additional ethical approval.
Informed consent
All analyses were performed using publicly available GWAS datasets. The GWAS studies cited in this research have received approval from their respective ethical review boards and have complied with informed consent requirements from participants.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhu, Y., Zhou, X., Jia, J. et al. Causal associations between 25-hydroxyvitamin D levels and NMOSD: a two-Sample Mendelian randomization analysis. Neurol Sci 45, 2379–2381 (2024). https://doi.org/10.1007/s10072-023-07290-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-023-07290-x